Eli Lilly is stockpiling its weight loss pill, plus Nvidia reveals new partners
Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just in time for the last hour of trading on Wall Street. Market update: The market received a boost after The Wall Street Journal reported that President Donald Trump and Chinese President Xi Jinping will discuss halving the 20% tariff on chemicals used to produce fentanyl at their upcoming meeting. If this happens, the average tariff on most Chinese goods would drop to 45%. More partners for Nvidia: Nvidia is making a bunch of headlines at its GTC conference in Washington, D.C. One notable announcement was a $1 billion investment in Finnish telecom company Nokia . The two companies formed a strategic partnership to develop next-generation 6G cellular technology. Nvidia is also teaming up with T-Mobile to integrate AI-RAN technologies into its 6G development. The world needs a network that can handle all the computing needs of the many AI-native devices and applications expected to be developed in the coming years. That’s why Nvidia’s partnership with telecom providers makes a lot of sense. It’s difficult to keep up with all the headlines coming out of the event, including a collaboration with Oracle to build the Department of Energy’s largest AI supercomputer for scientific discovery and a partnership with CrowdStrike to make cybersecurity AI agents. CEO Jensen Huang also put out some rosy numbers around the ramp of Grace Blackwell, its next-generation AI chip, over the next five quarters. All the news is resulting in Nvidia shares rallying about 3% to a fresh record high. Drugmaker ramps up : Eli Lilly is stocking up on its oral weight loss pill. Speaking at an event hosted by the Economic Club of Chicago on Monday, Eli Lilly CEO David Ricks said the company has already made “billions of doses” of the pill, called orforglipron, for its expected launch next year. “That will make this sort of the ‘GLP-1 for all,” Ricks said. Eli Lilly hasn’t yet submitted orforgElipron for FDA approval but is expected to do so before the end of the year. Eli Lilly reports its third-quarter earnings on Thursday before the opening bell, and this orforglipron stockpile isn’t going to sway the quarter. But it shows a whole lot of confidence in the upcoming launch, and it’s good to know the medication won’t experience the same type of supply bottlenecks as the injections (Mounjaro and Zepbound) originally did. Up next: Visa , Enphase Energy , ONEOK , Bloom Energy , Booking Holdings , Seagate Technology , Mondelez International , and Caesars Entertainment report earnings after the bell. Boeing , Verizon , GE Healthcare , CVS Health , Caterpillar , Otis , Fiserv , Centene , Etsy , Brinker International , and American Electric Power report on Wednesday before the bell. Tomorrow is also Fed day, with the Federal Open Markets Committee expected to lower interest rates by 25 basis points to a range of 3.75% to 4.00%. (See here for a full list of the stocks in Jim Cramer’s Charitable Trust.) As a subscriber to the CNBC Investing Club with Jim Cramer, you will receive a trade alert before Jim makes a trade. Jim waits 45 minutes after sending a trade alert before buying or selling a stock in his charitable trust’s portfolio. If Jim has talked about a stock on CNBC TV, he waits 72 hours after issuing the trade alert before executing the trade. THE ABOVE INVESTING CLUB INFORMATION IS SUBJECT TO OUR TERMS AND CONDITIONS AND PRIVACY POLICY , TOGETHER WITH OUR DISCLAIMER . NO FIDUCIARY OBLIGATION OR DUTY EXISTS, OR IS CREATED, BY VIRTUE OF YOUR RECEIPT OF ANY INFORMATION PROVIDED IN CONNECTION WITH THE INVESTING CLUB. NO SPECIFIC OUTCOME OR PROFIT IS GUARANTEED.
<
